SARS no longer deadly threat - But avian flu is

USA - Scientists are confident that the virus that caused severe acute respiratory syndrome (SARS) is no longer circulating in humans, or other animals, according to Professor Kathryn Holmes, a microbiology expert at the University of Colorado, USA.

Only if the SARS virus could evolve again - as an identical mutation of the original animal coronavirus - or if it were accidentally released from a lab - could it become a threat again, she said at a recent meeting of the American Association for the Advancement of Science.

Indeed, after the epidemic, the virus escaped, three times, from research centres in Taiwan, Beijing and Singapore. However, just nine people were infected and the elderly mother of an infected Chinese lab assistant died. Now, even if such an accident or mutation should occur, Prof. Holmes said, there several SARS vaccines and treatments to block infection, and the quarantine methods are better understood.

Avian ‘flu - Nancy Cox, chief influenza scientist at the US Centres for Disease Control, has called the threat from the avian influenza virus - which has killed 42 people in Asia - ‘very frightening’. Its death rate is now 76% - compared with 1% for the Spanish flu that killed about 40 million people in 1918-19.

01.03.2005

More on the subject:

Related articles

Photo

News • New insights on nosocomial pathogen

Research reveals ‘hidden movement’ of Pseudomonas aeruginosa

Pseudomonas aeruginosa, a hospital-acquired bacterium that causes serious infections, can move from the lungs to the gut inside the same patient, raising the risk of sepsis, new research reveals.

Photo

News • Bacteria-eating viruses

New phages spark hope against hospital superbug

A team of researchers comprehensively catalogued a new collection of bacteria-eating viruses called phages. These phages could be used to combat Klebsiella pneumoniae - a serious threat in hospitals.

Photo

News • Research reveals infiltrating microbes

How bacteria in tumors drive treatment resistance in cancer

Researchers have discovered a previously unknown mechanism that explains how bacteria within a tumor can drive treatment resistance in patients with oral and colorectal cancer.

Related products

Subscribe to Newsletter